Gahl Levy
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Aging top 10%
Papers in
-
- Liver physiology and pathology 4
- Hepatitis C virus research 2
-
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Yaakov Nahmias (10 shared papers)Merav Cohen (8 shared papers)David Bomze (3 shared papers)Elishai Ezra Tsur (4 shared papers)Daniel Kitsberg (3 shared papers)Magnus S. Jaeger (3 shared papers)Sebastian Prill (3 shared papers)Danny Bavli (3 shared papers)
- Journals
- Biomedical Microdevices (1 paper)Scientific Reports (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Hepatology (1 paper)Nature Chemical Biology (1 paper)
- Partner nations
- IsraelGermanyUnited States
In The Last Decade
Gahl Levy
13 papers receiving 1.2k citations
Gahl Levy's Hit Papers
Peers
Comparison fields: 5 of 95
- Hepatology 161
- Aging 20
- Molecular Biology 618
- Pharmacology 73
- Cancer Research 118
Countries citing papers authored by Gahl Levy
This map shows the geographic impact of Gahl Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gahl Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gahl Levy more than expected).
Fields of papers citing papers by Gahl Levy
This network shows the impact of papers produced by Gahl Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gahl Levy. The network helps show where Gahl Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside Gahl Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells Hit paper breakdown → | 2015 | 527 |
| 2 | 2016 | 270 | |
| 3 | 2015 | 113 | |
| 4 | 2015 | 63 | |
| 5 | 2021 | 57 | |
| 6 | 2015 | 56 | |
| 7 | 2016 | 41 | |
| 8 | 1984 | 11 | |
| 9 | 2015 | 10 | |
| 10 | 2018 | 8 | |
| 11 | 2014 | 7 | |
| 12 | 2014 | 3 | |
| 13 | 2018 | 2 |
About Gahl Levy
Gahl Levy is a scholar working on Hepatology, Epidemiology, Molecular Biology, Pharmacology and Biomedical Engineering, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), 3D Printing in Biomedical Research (2 papers), Hepatitis C virus research (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Hepatology (161 citations), Aging (20 citations), Molecular Biology (618 citations), Pharmacology (73 citations) and Cancer Research (118 citations). Gahl Levy has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Yaakov Nahmias, Merav Cohen, David Bomze, Elishai Ezra Tsur, Daniel Kitsberg, Magnus S. Jaeger, Sebastian Prill, Danny Bavli, Arieh Moussaieff and Joseph Itskovitz‐Eldor. Their work appears in journals such as Biomedical Microdevices, Scientific Reports, Journal of Pharmacology and Experimental Therapeutics, Hepatology and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.